Semak produk · pemegang pendaftaran
Pemegang pendaftaran · daftar NPRAJOHNSON & JOHNSON SDN. BHD.
81
pendaftaran produk atas nama syarikat ini
18
pengilang berbeza direkodkan pada produk tersebut
Ya
sekurang-kurangnya satu produk direkodkan dibuat oleh syarikat lain
Pengilang yang direkodkan
Daftar NPRA merekodkan pemegang pendaftaran dan pengilang secara berasingan. Ini adalah pengilang yang direkodkan pada produk syarikat ini.
| Pengilang | Produk |
|---|---|
| CILAG AG | 25 |
| JANSSEN CILAG SPA | 12 |
| JANSSEN PHARMACEUTICA N.V. | 11 |
| Excella GmbH & Co.KG | 9 |
| JANSSEN CILAG MANUFACTURING L.L.C | 6 |
| JANSSEN PHARMACEUTICA | 2 |
| JANSSEN ORTHO LLC | 2 |
| Oncotec Pharma Produktion GmbH | 2 |
| Janssen Biologics B.V. | 2 |
| PENN PHARMACEUTICAL SERVICES LIMITED | 2 |
| PATHEON INC | 1 |
| JANSSEN-CILAG S.P.A. | 1 |
| Haupt Pharma Wuelfing GmbH | 1 |
| PATHEON FRANCE S.A. | 1 |
| Catalent CTS, LLC. | 1 |
| Renaissance Lakewood LLC | 1 |
| Recipharm Pharmaservices Private Limited | 1 |
| BSP Pharmaceuticals S.p.A. | 1 |
Produk berdaftar — 60 daripada 81
| No. pendaftaran | Produk | Kategori | Tamat |
|---|---|---|---|
| MAL20013561ARZ | TOPAMAX TABLET 100MG | Ubat terkawal (preskripsi) | 19 Nov 2031 |
| MAL20013558ARZ | TOPAMAX TABLET 25MG | Ubat terkawal (preskripsi) | 19 Nov 2031 |
| MAL20013560ARZ | TOPAMAX TABLET 50MG | Ubat terkawal (preskripsi) | 19 Nov 2031 |
| MAL21116003AZ | Tremfya One-Press 100mg/ml Solution for Injection | Ubat terkawal (preskripsi) | 18 Nov 2031 |
| MAL21106013ACRZ | Velcade 3.5mg for Injection (sterile lyophilized powder) | Ubat terkawal (preskripsi) | 9 Okt 2031 |
| MAL26086138ACRZ | OPSYNVI (10mg macitentan/ 20mg tadalafil) film-coated tablets | Ubat terkawal (preskripsi) | 6 Ogo 2031 |
| MAL26086139ACRZ | OPSYNVI (10mg macitentan/ 40mg tadalafil) film-coated tablets | Ubat terkawal (preskripsi) | 6 Ogo 2031 |
| MAL19962530AZ | EPREX PREFILLED SYRINGE 2000IU/0.5ML | Ubat terkawal (preskripsi) | 1 Ogo 2031 |
| MAL19962533AZ | EPREX PREFILLED SYRINGE 10000IU/ML | Ubat terkawal (preskripsi) | 1 Ogo 2031 |
| MAL19962532AZ | EPREX PREFILLED SYRINGE 4000IU/0.4ML | Ubat terkawal (preskripsi) | 1 Ogo 2031 |
| MAL20076070ACZ | SIRTURO 100MG TABLETS | Ubat terkawal (preskripsi) | 12 Jul 2031 |
| MAL26076012AZ | STELARA 45 mg/0.5 mL One-Press Solution for Injection in Pre-filled Pen | Ubat terkawal (preskripsi) | 7 Jul 2031 |
| MAL26076013AZ | STELARA 90 mg/1 mL One-Press Solution for Injection in Pre-filled Pen | Ubat terkawal (preskripsi) | 7 Jul 2031 |
| MAL20112139AZ | STELARA 45MG/0.5ML SOLUTION FOR INJECTION IN PREFILLED SYRINGE | Ubat terkawal (preskripsi) | 30 Mei 2031 |
| MAL20112140AZ | STELARA 90MG/1ML SOLUTION FOR INJECTION IN PREFILLED SYRINGE | Ubat terkawal (preskripsi) | 30 Mei 2031 |
| MAL05072100ARZ | CONCERTA 18 mg Extended-release Tablet | Ubat terkawal (preskripsi) | 30 Apr 2031 |
| MAL05072101ARZ | CONCERTA 36 mg Extended-release Tablet | Ubat terkawal (preskripsi) | 30 Apr 2031 |
| MAL08061554ARZ | CONCERTA 27 mg Extended-release Tablet | Ubat terkawal (preskripsi) | 30 Apr 2031 |
| MAL16045047AZ | SIMPONI IV 12.5mg/1ml Concentrate for Solution for Infusion | Ubat terkawal (preskripsi) | 30 Apr 2031 |
| MAL16045042AZ | Invokana 100mg Film-Coated Tablets | Ubat terkawal (preskripsi) | 30 Apr 2031 |
| MAL16045038AZ | Invokana 300mg Film-Coated Tablets | Ubat terkawal (preskripsi) | 30 Apr 2031 |
| MAL21036003ACZ | SPRAVATO 28mg Nasal Spray | Ubat terkawal (preskripsi) | 3 Mac 2031 |
| MAL16025029ACRZ | Imbruvica 140mg Capsules | Ubat terkawal (preskripsi) | 27 Feb 2031 |
| MAL26026004ARZ | LAZCLUZE 240mg Film-Coated Tablets | Ubat terkawal (preskripsi) | 3 Feb 2031 |
| MAL26026005ARZ | LAZCLUZE 80mg Film-Coated Tablets | Ubat terkawal (preskripsi) | 3 Feb 2031 |
| MAL26016012ACZ | Tecvayli 90 mg/mL Solution for Injection | Ubat terkawal (preskripsi) | 8 Jan 2028 |
| MAL26016011ACZ | Tecvayli 10 mg/mL Solution for Injection | Ubat terkawal (preskripsi) | 8 Jan 2028 |
| MAL20002243AZ | RISPERDAL TABLET 2MG | Ubat terkawal (preskripsi) | 5 Dis 2030 |
| MAL20002242AZ | RISPERDAL TABLET 1MG | Ubat terkawal (preskripsi) | 5 Dis 2030 |
| MAL20116008ACZ | ZYTIGA 500mg Film-Coated Tablet | Ubat terkawal (preskripsi) | 3 Nov 2030 |
| MAL05072016AZ | Sporanox Capsule 100mg | Ubat terkawal (preskripsi) | 1 Ogo 2030 |
| MAL20102034AZ | INVEGA SUSTENNA 150 MG PROLONGED RELEASE SUSPENSION FOR INTRAMUSCULAR INJECTION | Ubat terkawal (preskripsi) | 31 Mei 2030 |
| MAL20102031AZ | INVEGA SUSTENNA 50 MG PROLONGED RELEASE SUSPENSION FOR INTRAMUSCULAR INJECTION | Ubat terkawal (preskripsi) | 31 Mei 2030 |
| MAL20102032AZ | INVEGA SUSTENNA 75 MG PROLONGED RELEASE SUSPENSION FOR INTRAMUSCULAR INJECTION | Ubat terkawal (preskripsi) | 31 Mei 2030 |
| MAL20102033AZ | INVEGA SUSTENNA 100 MG PROLONGED RELEASE SUSPENSION FOR INTRAMUSCULAR INJECTION | Ubat terkawal (preskripsi) | 31 Mei 2030 |
| MAL15045159ACRZ | RIBOMUSTIN 25MG/VIAL POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION | Ubat terkawal (preskripsi) | 2 Mei 2030 |
| MAL15045157ACRZ | RIBOMUSTIN 100MG/VIAL POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION | Ubat terkawal (preskripsi) | 2 Mei 2030 |
| MAL20046067AZ | INVEGA TRINZA 175mg/0.875mL Prolonged-Release Suspension for Intramuscular Injection | Ubat terkawal (preskripsi) | 1 Mei 2030 |
| MAL20046069AZ | INVEGA TRINZA 350mg/1.750mL Prolonged-Release Suspension for Intramuscular Injection | Ubat terkawal (preskripsi) | 1 Mei 2030 |
| MAL20046070AZ | INVEGA TRINZA 525mg/2.625mL Prolonged-Release Suspension for Intramuscular Injection | Ubat terkawal (preskripsi) | 1 Mei 2030 |
| MAL20046068AZ | INVEGA TRINZA 263mg/1.315mL Prolonged-Release Suspension for Intramuscular Injection | Ubat terkawal (preskripsi) | 1 Mei 2030 |
| MAL20081768AZ | INVEGA 9 MG EXTENDED RELEASE TABLETS | Ubat terkawal (preskripsi) | 1 Mac 2030 |
| MAL20081767AZ | INVEGA 6 MG EXTENDED RELEASE TABLETS | Ubat terkawal (preskripsi) | 1 Mac 2030 |
| MAL20081766AZ | INVEGA 3 MG EXTENDED RELEASE TABLETS | Ubat terkawal (preskripsi) | 1 Mac 2030 |
| MAL20026041ARZ | Erleada 60mg Film-Coated Tablets | Ubat terkawal (preskripsi) | 14 Feb 2030 |
| MAL20016146ACRZ | Opsumit 10mg Film-Coated Tablets | Ubat terkawal (preskripsi) | 10 Jan 2030 |
| MAL22116003AZ | RYBREVANT 350mg/7mL Concentrate for Solution for Infusion | Ubat terkawal (preskripsi) | 4 Nov 2026 |
| MAL19992548AZ | RISPERDAL ORAL SOLUTION 1MG/ML | Ubat terkawal (preskripsi) | 2 Nov 2029 |
| MAL20041199AZ | REMICADE POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION | Ubat terkawal (preskripsi) | 19 Okt 2029 |
| MAL19106010AZ | STELARA 130mg/26mL Concentrate for Solution for Infusion | Ubat terkawal (preskripsi) | 4 Okt 2029 |
| MAL20041085ACRZ | TRACLEER TABLET 125 MG | Ubat terkawal (preskripsi) | 14 Sep 2029 |
| MAL19096009AZ | TREMFYA 100MG/ML SOLUTION FOR INJECTION | Ubat terkawal (preskripsi) | 6 Sep 2029 |
| MAL20091917AZ | REMINYL Prolonged Release Capsules 24mg | Ubat terkawal (preskripsi) | 29 Jun 2029 |
| MAL20091915AZ | REMINYL Prolonged Release Capsules 8mg | Ubat terkawal (preskripsi) | 29 Jun 2029 |
| MAL20091916AZ | REMINYL Prolonged Release capsules 16mg | Ubat terkawal (preskripsi) | 29 Jun 2029 |
| MAL19056121ASZ | Imbruvica 140mg Capsules | Ubat terkawal (preskripsi) | 31 Mei 2029 |
| MAL19046001ARZ | Prezista 600mg Film Coated Tablet | Ubat terkawal (preskripsi) | 5 Apr 2029 |
| MAL23126007AZ | INVEGA HAFYERA 700 mg/3.5 mL Prolonged-Release Suspension for Intramuscular Injection | Ubat terkawal (preskripsi) | 7 Dis 2028 |
| MAL23126006AZ | INVEGA HAFYERA 1000 mg/5.0 mL Prolonged-Release Suspension for Intramuscular Injection | Ubat terkawal (preskripsi) | 7 Dis 2028 |
| MAL19871481ACZ | STUGERON 25MG TABLET | Ubat terkawal (preskripsi) | 7 Okt 2028 |
Sumber data: National Pharmaceutical Regulatory Agency (NPRA), Ministry of Health Malaysia, diterbitkan di data.gov.my · rekod setakat 3 Sep 2026 · dilesenkan di bawah CC BY 4.0.
Laman ini melaporkan rekod pendaftaran seperti yang diterbitkan. Produk yang tidak ditemui dalam set data ini mungkin tidak pernah didaftarkan, atau pendaftarannya telah tamat — ketiadaan rekod bukan pengesahan bahawa sesuatu produk sesuai digunakan. Rujuk NPRA untuk maklumat rasmi. Laporkan rekod yang salah.